Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Teva
Colorcon
Farmers Insurance
Merck
Chinese Patent Office
Harvard Business School
Federal Trade Commission
US Army

Generated: June 21, 2018

DrugPatentWatch Database Preview

Delcor Asset Company Profile

« Back to Dashboard

What is the competitive landscape for DELCOR ASSET, and what generic and branded alternatives to DELCOR ASSET drugs are available?

DELCOR ASSET has seventeen approved drugs.



Summary for Delcor Asset
US Patents:0
Tradenames:7
Ingredients:6
NDAs:17
Patent Litigation for Delcor Asset: See patent lawsuits for Delcor Asset

Drugs and US Patents for Delcor Asset

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp KENALOG triamcinolone acetonide LOTION;TOPICAL 011602-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp KENALOG triamcinolone acetonide LOTION;TOPICAL 084343-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp KENACORT triamcinolone TABLET;ORAL 011283-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp KENACORT triamcinolone TABLET;ORAL 011283-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Accenture
Express Scripts
Medtronic
Teva
Deloitte
Federal Trade Commission
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.